The European Commission has asked SCHEER to assess the potential health risks associated with LED emissions in the general population. The review of the published research conducted by the Committee has resulted in valuable conclusions and identified certain gaps in the knowledge on potential risks to human health from LEDs.
The Committee concluded that there is no evidence of direct adverse health effects from LEDs in normal use (lightening and displays) by the healthy general population.
Vulnerable and susceptible population (young children, adolescent and elderly people) were studied separately. Children have a higher sensitivity to blue light. Although emissions may not be harmful, blue LEDs may be very dazzling and may induce photochemical retinopathy, which is a concern especially for children below three years of age. Moreover, elderly people may experience discomfort from exposure to LED systems, including blue LED displays.
Despite the existence of cellular and animal studies showing adverse effects of LED exposure, their conclusions derive from results obtained using exposure conditions that are difficult to relate to human exposures or using exposure levels greater than those likely to be achieved with LED lighting systems in practice.
Since the use of LED technology is still evolving, the Committee considers that it is important to closely monitor the risk of adverse health effects from long term LED use to the general population.
For more information on the public consultation of Light Emitting Diodes (LEDs).
Cross-country variation in health expenditure may be the result of differences in the prices of goods and services or differences in the volume of care, or a mix of both. Separating health spending into volume and price measures helps policy makers better understand the drivers of cross-country variations, and helps them decide what policy responses should be put in place to address health spending trends. Such policies may differ if, for example, a country’s high health care spending is due to relatively high volume of goods and services consumed or to the relatively high price a country pays for those goods or services.
The OECD have recently published new findings on these international comparisons.
To download the document on International comparisons of health prices and volumes from the oecd.org website
Each year, an estimated 78 million people are infected with gonorrhoea, which can infect the genitals, rectum, and throat. Complications of gonorrhoea disproportionally affect women and can include pelvic inflammatory disease, ectopic pregnancy and infertility, as well as an increased risk of HIV.
Data from 77 countries show that antibiotic resistance is making gonorrhoea more difficult, and sometimes impossible, to treat. Some countries – particularly high-income ones, where surveillance is best – are finding cases of the infection that are untreatable by all known antibiotics. These cases may just be the tip of the iceberg, as gonorrhoea is more common in lower-income countries.
Currently, in most countries, ESCs are the only single antibiotic that remain effective for treating gonorrhoea. But resistance to cefixime – and more rarely to ceftriaxone – has now been reported in more than 50 countries. As a result, WHO issued updated global treatment recommendations in 2016 advising doctors to give 2 antibiotics: ceftriaxone and azithromycin.
For more information about Antibiotic-resistant gonorrhoea on the who.int website
The European Parliament funds a number of pilot projects designed to test the feasibility and usefulness of action, develop evidence-based strategies to address a problem, identify good practices, and provide policy guidance in the area of health inequalities.
One such pilot is VulnerABLE: Improving the health of those in isolated and vulnerable situations
It targets specific vulnerable and isolated populations such as children and families from disadvantaged backgrounds; those living in rural/isolated areas; those with physical, mental and learning disabilities or poor mental health; the long-term unemployed; the inactive; the ‘in-work poor’; older people; victims of domestic violence and intimate partner violence; people with unstable housing situations (the homeless); and prisoners.
Due to their circumstances, these groups may be more at risk of poor health and/or face barriers in accessing healthcare services. The project will assess their particular health needs and challenges, as well as identify best practices to support them and ultimately improve their health.
Initial research has found that unmet health needs are a significant factor for those living in vulnerable and isolated situations. For example:
- Data from the Survey of Health, Ageing and Retirement in Europe (SHARE) show that in older people socioeconomic factors such as a lower level of education and lower income increase the likelihood of older people experiencing limitations to their mobility, and the prevalence of eyesight, hearing and chewing problems
- Those living in rural areas are less likely than urban residents to seek the healthcare they need because of cost, distance, and/or a lack of health facilities and professionals
- Most prisoners have pre-existing vulnerabilities, such as substance abuse and mental health needs, which overcrowding and poor hygiene in prison may make worse
- Those with lower levels of education are more likely to have a lower life expectancy
- Long-term unemployment and inactivity is associated with a range of poor health outcomes
Over its two-year lifetime, the ‘VulnerABLE’ project will create training materials and capacity-building workshops for national and regional authorities who deliver healthcare services and have a vital role to play in tackling health inequalities
For more information about Pilot projects to tackle Health Inequalities on the ec.europa.eu website
Public health officials regularly collect and analyse data to map disease, spot patterns, identify causes and respond to outbreaks. Surveillance, when conducted ethically, is the foundation for programs to promote human well-being at the population level and can contribute to reducing inequalities.
However, it is not without risks for participants and sometimes poses ethical dilemmas. It can lead to harm if people’s privacy is violated, or they are stigmatized on the basis of the information they provide about themselves.
The WHO have produced Guidelines on Ethical Issues in Public Health Surveillance – the first international framework of its kind. It outlines 17 ethical guidelines that can assist everyone involved in public health surveillance, including officials in government agencies, health workers, NGOs and the private sector.
To read the Guidelines on Ethical Issues in Public Health Surveillance
The Swedish government has introduced a new national mental health strategy for 2016-2020. It is based on five focus areas identified as the most important to strengthen mental health and prevent mental illness:
- Prevention and promotion efforts
- Accessible early interventions
- Focus on vulnerable groups
- Participation and rights
- Organization and leadership
Each focus area includes people of all ages – children, young people, adults, and the elderly. Just as the focus areas were developed in collaboration between many different stakeholders, the government emphasises that all development work in the field must be conducted simultaneously and collaboratively. The Public Health Agency of Sweden plays a leading role in this effort.
For more information about Sweden’s National Mental Health Strategy on the eurohealthnet-magazine.eu website
The EU has published its Action Plan to tackle Antimicrobial Resistance (AMR) – a growing threat that is responsible for 25,000 deaths and a loss of €1.5 billion in the EU every year.
The plan includes guidelines for doctors, nurses, pharmacists, hospital administrators and others who play a role in antimicrobial use to promote their prudent use in people. These guidelines complement infection prevention and control guidelines which may exist at national level. In addition, the plan foresees more than 75 actions built on three main pillars:
- making the EU a best-practice region
- boosting research, development and innovation
- shaping the global agenda
For more information on the Action Plan to tackle Antimicrobial Resistance on the ec.europa.eu website
Unhealthy diets and low physical activity contribute to many chronic diseases and disability; they are responsible for some 2 in 5 deaths worldwide and for about 30% of the global disease burden. Yet surprisingly little is known about the economic costs that these risk factors cause, both for health care and society more widely.
This study pulls together the evidence about the economic burden that can be linked to unhealthy diets and low physical activity.
The study’s findings are a step towards a better understanding of the economic burden that can be associated with two key risk factors for ill health and they will help policymakers in setting priorities and to more effectively promoting healthy diets and physical activity.
To download the report Assessing the costs of unhealthy diet and low physical activity from the euro.who.int websit
1 in 5 children in high-income countries lives in relative income poverty and an average of 1 in 8 faces food insecurity, according to the latest report by the UNICEF Office of Research.
This report ‘Building the Future: children and the sustainable development goals in rich countries’ is the first report to assess the status of children in 41 high-income countries in relation to the Sustainable Development Goals (SDGs) identified as most important for child well-being. It ranks countries based on their performance and details the challenges and opportunities that advanced economies face in achieving global commitments to children.
To download the report on the status of children in high-income countries from the unicef-irc.org website
Each year, at least 1.4 million Europeans die prematurely due to polluted environments; this corresponds to at least 15% of Europe’s total deaths. Around half of these deaths are due to outdoor and indoor air pollution. Altogether, European citizens lose annually 50 million years of healthy life from environmental risks.
Environmental risk factors are responsible for around 26% of ischemic heart disease, 25% of strokes and 17% of cancers in Europe. Air pollution is the leading environmental killer, responsible for 620,000 deaths every year from outdoor (transport, industry, energy production) and indoor (solid fuel combustion for heating and cooking, poor ventilation, second-hand tobacco smoke) exposure.
For more information about the risks to public health of air pollution on the euro.who.int website